Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
StoneCo
STNE
$2.72B
| $817K | ﹤0.01% |
20,490
+19,410
| +1,797% | +$710K |
|
3802
Vericel Corp
VCEL
$2.32B
| $817K | ﹤0.01% |
46,894
+23,715
| +102% | +$404K |
|
3803
Fortuna Silver Mines
FSM
$2.91B
| $816K | ﹤0.01% |
200,037
-45,659
| -19% | -$149K |
|
|
SNV
3804
CALL
DELISTED
Synovus
SNV
| $815K | ﹤0.01% |
20,800
+9,600
| +86% | +$353K |
|
|
MOFG
3805
DELISTED
MidWestOne Financial Group
MOFG
| $814K | ﹤0.01% |
22,464
+4,203
| +23% | +$140K |
|
3806
CALL
Polaris
PII
$4.16B
| $814K | ﹤0.01% |
8,000
-200
| -2% | -$19.4K |
|
|
RC
3807
Ready Capital
RC
$278M
| $814K | ﹤0.01% |
52,848
+33,753
| +177% | +$532K |
|
3808
CALL
Cal-Maine
CALM
$4.02B
| $808K | ﹤0.01% |
18,900
-17,500
| -48% | -$729K |
|
3809
Ternium
TX
$10.5B
| $805K | ﹤0.01% |
36,531
+17,089
| +88% | +$348K |
|
3810
Bally's
BALY
$686M
| $804K | ﹤0.01% |
31,372
+5,946
| +23% | +$143K |
|
3811
CALL
NOV
NOV
$6.95B
| $804K | ﹤0.01% |
32,100
+12,400
| +63% | +$279K |
|
|
SC
3812
PUT
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $804K | ﹤0.01% |
34,400
-87,400
| -72% | -$2.12M |
|
|
3813
PUT
Polaris
PII
$4.16B
| $803K | ﹤0.01% |
7,900
+2,300
| +41% | +$223K |
|
3814
PUT
ProShares Ultra Bloomberg Crude Oil
UCO
$368M
| $802K | ﹤0.01% |
6,272
-3,344
| -35% | -$372K |
|
|
EB
3815
DELISTED
Eventbrite
EB
| $800K | ﹤0.01% |
39,631
-174,248
| -81% | -$3.33M |
|
|
NGM
3816
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $800K | ﹤0.01% |
43,314
+14,398
| +50% | +$210K |
|
3817
CALL
CenterPoint Energy
CNP
$26.8B
| $799K | ﹤0.01% |
29,300
-76,800
| -72% | -$2.09M |
|
3818
Nordson
NDSN
$17.3B
| $799K | ﹤0.01% |
4,911
-10,992
| -69% | -$1.74M |
|
3819
PUT
Host Hotels & Resorts
HST
$17.2B
| $796K | ﹤0.01% |
42,900
+24,800
| +137% | +$429K |
|
3820
Parsons
PSN
$5.1B
| $795K | ﹤0.01% |
19,257
+2,556
| +15% | +$95.4K |
|
|
LM
3821
DELISTED
Legg Mason, Inc.
LM
| $795K | ﹤0.01% |
22,136
-66,049
| -75% | -$2.45M |
|
3822
Ethan Allen Interiors
ETD
$614M
| $794K | ﹤0.01% |
41,732
-5,270
| -11% | -$98.2K |
|
3823
NRC Health Common Stock
NRC
$432M
| $794K | ﹤0.01% |
12,043
+5,449
| +83% | +$333K |
|
|
WCG
3824
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
| $793K | ﹤0.01% |
2,400
-5,600
| -70% | -$1.68M |
|
3825
Copa Holdings
CPA
$6.15B
| $791K | ﹤0.01% |
7,320
-11,529
| -61% | -$1.2M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.